1 / 29

Newer Antidepressants and Serotonin Syndrome

Newer Antidepressants and Serotonin Syndrome. Presented by Dr. Bloxdorf Prepared by A. Hillier. General Principles. Newer antidepressants termed atypical, heterocyclic or second generation

Leo
Télécharger la présentation

Newer Antidepressants and Serotonin Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Newer Antidepressants and Serotonin Syndrome Presented by Dr. Bloxdorf Prepared by A. Hillier

  2. General Principles • Newer antidepressants termed atypical, heterocyclic or second generation • Prescribed for depression, anxiety disorder, panic disorder, personality disorders, OCD and eating disorders • Differentiated from TCA’s and MAOI’s ▪ More selective ▪ Less toxicity ▪ Fewer fatalities • More likely to produce Serotonin Syndrome

  3. General Principles • No cardiotoxicity or conduction delays that are seen with TCA’s • No associated tyramine reactions like MAOI’s • Negligible affinity for acetylcholine, dopamine, GABA-A, glutamate or β-adrenergic receptors • Higher safety margin than MAOI’s and TCA’s

  4. General Principles • Poorly cleared by hemodialysis, hemofiltration, forced diuresis, whole bowel irrigation or activated charcoal • Not detected by routine plasma/urine testing • Primarily CYP-450 hepatic metabolization • If taken with MAOI’s may precipitate serotonin syndrome

  5. Trazodone-Overview • Indicated for depression and insomnia • Low fatality rate (1 in 1200 exposures) • Unrelated to other antidepressants • Half-life up to 13 hours with overdose • Common side effects ▪ Priapism ▪ Drowsiness ▪ Dry mouth ▪ Nausea ▪ Orthostatic hypotension

  6. Trazodone-Acute Overdose • No established toxic dose-no serious toxicity up to 2 grams • Most common is CNS depression • Severe Ingestion ▪ Ataxia ▪ Dizziness ▪ Seizures ▪ Coma ▪ Hypotension • Treatment ▪ Supportive ▪ Charcoal ▪ Lavage for massive ingestion

  7. Bupropion-Overview • Indicated for depression and nicotine cessation • Half-life up to 20 hours • Common side effects ▪ Dry mouth ▪ Dizziness ▪ Confusion ▪ Agitation ▪ Nausea ▪ Blurred vision ▪ Headache ▪ Constipation ▪ Tremor • Rare side effects ▪ Rash ▪ Stevens-Johnson ▪ Seizure

  8. Bupropion-Acute Overdose • Low-toxic-to therapeutic ratio • Most common-sinus tachycardia • Severe Ingestion ▪ Lethargy ▪ Generalized seizure ▪ Coma ▪ Cardiac arrest • Treatment ▪ Gastric Lavage ▪ Activated charcoal ▪ Benzodiazepines ▪ Phenobarbital

  9. Nefazodone-Acute Overdose • Relatively safe in overdose • No fatalities with overdose up to 11 grams • Most common symptoms ▪ Nausea ▪ Vomiting ▪ Somnolence • Supportive Treatment Mirtazapine-Acute Overdose • Limited toxicity in overdose • Most common symptoms ▪ Sedation ▪ Confusion ▪ Sinus tachycardia ▪ Mild hypertension • Supportive Treatment

  10. Selective Serotonin Receptor Inhibitors • Inhibit presynaptic serotonin reuptake • Most commonly prescribed class of antidepressants • Fatalities uncommon (1 in 1000) • Long half life (15 hours up to 14 days)

  11. Selective Serotonin Receptor Inhibitors • Adverse events ▪ Nausea ▪ Anorexia ▪ Serotonin syndrome ▪ Headache ▪ Sedation ▪ Insomnia ▪ Dizziness ▪ Fatigue ▪ Tremor ▪ Nervousness ▪ Seizures ▪ Extrapyramidal symptoms ▪ SIADH

  12. Selective Serotonin Receptor Inhibitors • Acute Overdose • High therapeutic-to-toxic ratio • Fatalities uncommon • 50% of overdoses remain asymptomatic • Most symptoms similar to adverse event profile • Less frequent ▪ Agitation ▪ Hallucinations ▪ Seizures ▪ Hypertension ▪ Hypotension ▪ Widened QRS ▪ Prolonged QTc

  13. Selective Serotonin Receptor Inhibitors • Treatment • IV • Cardiac monitor • Activated charcoal 1 gm/kg • Gastric lavage probably unnecessary • Syrup of Ipecac-contraindicated • Prolonged QRS/QTc-Sodium bicarbonate • Seizures-Benzodiazepines • Serotonin syndrome-Cyproheptadine

  14. Venlafaxine-Acute Overdose • Half-life of 11 hours • Most common effects ▪ Tachycardia ▪ Hypertension ▪ Diaphoresis ▪ Tremor ▪ Mydriasis ▪ Sedation • More severe effects ▪ Coma ▪ Generalized seizures ▪ Widened QRS ▪ Prolonged QTc

  15. Venlafaxine-Acute Overdose • Treatment • IV • Monitor • Gastric lavage • Activated charcoal • Seizures-Benzodiazepines • QRS widening-Sodium bicarbonate • Hypertension-Nitroprusside/Esmolol or Phentolamine • Avoid β-blockers

  16. Serotonin Syndrome • Rare idiosyncratic drug-induced reaction • Most cases occur at therapeutic levels • Less than 13% occur with overdose • Characterized by alterations in • Cognition and behavior • Autonomic nervous system • Neuromuscular activity • Mortality rate of 11%

  17. Serotonin Syndrome • SS most often occurs after routine medication increase or addition of another 5-HT stimulating agent • True incidence of SS is unknown • SS is often difficult to diagnose because of varying symptoms ▪ Mild cases attributed to psychiatric disorders ▪ More severe cases attributed to NMS • EP’s may inadvertently precipitate SS by prescribing tramadol, dextromethorphan or meperidine

  18. Serotonin Signs and Symptoms

  19. Serotonin Syndrome • Muscle rigidity • Most often found in the lower extremities-may be valuable clinical marker • Ataxia • Check for lower extremity hypertonia • Hyperthermia • Usually mild-moderate, but reports up to 41oC • Seizures • Always generalized and usually short lived

  20. Serotonin Syndrome • Unilateral muscle rigidity or focal neurologic findings have not been reported • Hypertension reported twice as often as hypotension • SS is a clinical diagnosis • Lab testing done to rule-out other causes of symptoms

  21. Serotonin Syndrome • Treatment • No accepted guidelines for SS treatment • Stop offending drugs • Benzodiazepines for patient comfort and rigidity • Monitor closely for rhabdomyolysis and metabolic acidosis • Approximately 25% will require intubation • Usually dramatic improvement within 24 hours

  22. Serotonin Syndrome Medications • Cyproheptadine • Initial dose: 4-8 mg PO • May repeat in 2 hours if no response • Discontinue is no response noted after 16 mg • Dantrolene • 0.5-2.5 mg/kg IV every 6 hours • Maximum 10 mg/kg in 24 hours

  23. Summary • SSRI overdose pales in comparison to MAOI’s and TCA’s • Still can have significant morbidity and mortality • Most of the management is supportive after decontamination • Beware of tramadol, dextromethorphan and meperidine in anyone taking SSRI’s, TCA’s or MAOI’s

  24. Questions • All of the following may precipitate serotonin syndrome except: • Paroxetine • Meperidine • Fentanyl • Tramadol • Dextromethorphan

  25. Questions • Serotonin syndrome may present like all of the following except: • Sympathomimetic syndrome • Neuroleptic malignant syndrome • Acute psychosis • Rhabdomyolysis • Acute unilateral stroke

  26. Questions • Basic management for any acute overdose consist of: • Rectal exam • Call poison control • HgbA1C • VDRL/RPR • Punitive Gastric Lavage

  27. Questions • All of the following are included in the serotonin syndrome triad except: • Hepatic dysfunction • Cognitive dysfunction • Autonomic dysfunction • Neuromuscular dysfunction

  28. Questions • With the newer class of antidepressants which of the following are true: • There are not detected by routine lab tests • Treatment is mostly supportive • They are poorly cleared by hemodialysis, forced diuresis or activated charcoal • Have no significant interactions with MAOI’s • All of the above are true

  29. Answers • C-Fentanyl has never been reported to precipitate SS, however all the others can • E-SS may present like all the other responses, but acute focal CVA should make you think of another diagnosis • B-Even with the most mundane ingestion, you should make the call to Poison Control • A-Although due to rhabdomyolysis etc. you may see liver dysfunction, it is not part of the presenting triad • E-All of the above are true

More Related